On 22 January, Corning Inc. (NYSE:GLW) announced that it has acquired assets of NovaSol, a leading provider of advanced hyperspectral imaging systems. The terms of the agreement are not being disclosed. On Tuesday shares of Corning Inc. (NYSE:GLW) closed at $24.35. Company’s sales growth for last 5 years was 5.60% and EPS growth for next 5 years is recorded as 10.85%.
CH Robinson Worldwide Inc. (NASDAQ:CHRW) reported Q4 EPS of $0.77, $0.01 better than the analyst estimate of $0.76. Revenue for the quarter came in at $3.36 billion versus the consensus estimate of $3.33 billion. CH Robinson Worldwide Inc. (NASDAQ:CHRW) in last trading activity moved up 2.44% to close at $75.23. Company weekly performance is 2.02% while its quarterly performance stands at 9.28%. CH Robinson Worldwide Inc. (NASDAQ:CHRW) is -2.92% away from its 52 week high.
On 20 January, River Valley Bancorp (NASDAQ:RIVR) announced unaudited earnings for the fourth quarter and fiscal year ended December 31, 2014. For the year ended December 31, 2014, the Corporation reported net income of $4,788,000 or $2.21 per basic share. This is the highest dollar value recorded in the Corporation’s history and represents a 7.84% improvement from the net income of $4,440,000 or $2.67 per basic share reported for the year ended December 31, 2013. On last trading day River Valley Bancorp (NASDAQ:RIVR) moved up 0.10% to close at $20.12. Its volatility for the week is 1.63% while volatility for the month is 0.92%. RIVR’s sales growth for past 5 years was 0.50% and its EPS growth for past 5 years was 15.10%. River Valley Bancorp (NASDAQ:RIVR) monthly performance is -4.96%.
On 20 January, Galena Biopharma, Inc. (NASDAQ:GALE) announced it has hired Joseph Lasaga as Vice President, Business Development and Alliance Management, reporting to the President and CEO. Galena Biopharma, Inc. (NASDAQ:GALE) in last trading activity advanced 0.60% to close at $1.69. Company weekly performance is -1.17% while its quarterly performance stands at -17.56%. Galena Biopharma, Inc. (NASDAQ:GALE) is -69.05% away from its 52 week high.
Bemis Company, Inc. (NYSE:BMS) had its price target upped by Barclays from $38.00 to $39.00 in a research note issued to investors on Friday. The firm currently has an underweight rating on the stock. On last trading day Bemis Company, Inc. (NYSE:BMS) moved up 1.55% to close at $45.11. Its volatility for the week is 2.44% while volatility for the month is 1.89%. BMS’s sales growth for past 5 years was 5.90% and its EPS growth for past 5 years was 4.80%. Bemis Company, Inc. (NYSE:BMS) monthly performance is -0.15%.